Ms contin and Slow-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ms contin (morphine sulfate) and Slow-k (potassium chloride). Common drug interactions include sudden death among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Ms contin and Slow-k. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Ms contin?

Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.

What is Slow-k?

Slow-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 3,683 Slow-k users. Check the latest studies of Slow-k.



On Jul, 26, 2026

25 people who take Ms contin and Slow-k together, and have interactions are studied.

Ms contin and Slow-k drug interactions.

What are the common drug interactions of Ms Contin and Slow-K, by gender? *:

female:

  1. Sudden death
  2. Cardiac disorder
  3. Fall
  4. Hallucination (an experience involving the perception of something not present)
  5. Hip fracture
  6. International normalised ratio increased
  7. Arrhythmia (irregular heartbeat)
  8. Chest pain
  9. Confusion
  10. Confusional state

male:

  1. Asthenia (weakness)
  2. Haemoglobin decreased
  3. Pulmonary congestion (congestion in the lungs)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Abdominal pain
  6. Agitation (state of anxiety or nervous excitement)
  7. Anxiety
  8. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  9. Cellulitis (infection under the skin)
  10. Cholecystitis (infection of gallbladder)

What are the common drug interactions of Ms Contin and Slow-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Feeling of body temperature change
  2. Fluid retention (an abnormal accumulation of fluid in the blood)
  3. Headache (pain in head)
  4. Hepatic steatosis (fatty liver disease)
  5. Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
  6. Hyperbilirubinaemia (excess of bilirubin in the blood)
  7. Hypercholesterolaemia (high levels of cholesterol in the blood)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Hyperlipidaemia (presence of excess lipids in the blood)
  10. Hyperventilation

50-59:

  1. Asthenia (weakness)
  2. Haemoglobin decreased
  3. Retching (strong involuntary effort to vomit)
  4. Gastric ulcer (stomach ulcer)
  5. Haematocrit
  6. Perineal abscess
  7. Renal failure (kidney dysfunction)
  8. Weight decreased
  9. Abdominal pain upper
  10. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)

60+:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Cardiomegaly (increased size of heart than normal)
  3. Fluid overload (too much fluid in the blood)
  4. Haemoglobin decreased
  5. Platelet count decreased
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Alanine aminotransferase increased
  8. Blood creatinine increased
  9. Blood lactate dehydrogenase increased
  10. Blood potassium increased

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 7 people, 28.00%
  2. Back Pain: 4 people, 16.00%
  3. Stress And Anxiety: 2 people, 8.00%
  4. Rheumatic Fever (an inflammatory disease that occurs following a streptococcus pyogenes infection): 2 people, 8.00%
  5. Rectal Cancer Recurrent (reoccurrence of rectum cancer): 2 people, 8.00%
  6. Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 2 people, 8.00%
  7. Diarrhea: 2 people, 8.00%
  8. Diabetes: 2 people, 8.00%
  9. Depression: 2 people, 8.00%
  10. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ms contin and Slow-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ms contin and Slow-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Slow-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ms contin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Slow-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate and potassium chloride (the active ingredients of Ms contin and Slow-k, respectively), and Ms contin and Slow-k (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: